-+-+-+- NEXT SEGMENT -+-+-+- Segment of length 6014 From redacted@cybernothing.org Thu Jun 16 13:00:36 2005 Message-ID: <redacted@localhost.localdomain> From: redacted@no.thanks Subject: [email] Start y0ur trading day with a bang Approved: redacted@cybernothing.org Followup-To: news.admin.net-abuse.email Newsgroups: news.admin.net-abuse.sightings Organization: VeriMod (<URL:http://www.killfile.org/~tskirvin/verimod/>) Processed-By: Bob the NANAS ModBot <redacted@cybernothing.org> Verimod-Status: Thu Jun 16 13:00:36 2005 - posted X-Auth: PGPMoose V1.1 PGP news.admin.net-abuse.sightings iD8DBQFCsb5Ev1i8LqUfqQURAgzyAJwKLPGOsxSxL9M36lbTrfyHJO0+zACfVaui pzDrSrV8Aa8U+3IThCipkXk= =109e X-Group-Homepage: http://www.killfile.org/~tskirvin/nana/ X-Mail-Path: localhost.localdomain [UNTRUSTED]!redacted@localhost.localdomain X-Modbot: Bob the NANAS ModBot <redacted@cybernothing.org> X-Original-Date: Thu, 16 Jun 2005 18:37:56 GMT X-Original-To: redacted@killfile.org X-Submissions-To: redacted@cybernothing.org Spam. Unsolicited e-mail report follows: Memo #249007 (4624) From redacted@adecco.com Wed Jun 15 20:24:09 2005 Received: from ****************** (****************** [***************]) by **********.********* (8.11.3/***/8.11.2) with ESMTP id j5FJO9f22435; Wed, 15 Jun 2005 20:24:09 +0100 (BST) X-Envelope-From: redacted@adecco.com Received: from charter.com (18.98.205.68.cfl.res.rr.com [68.205.98.18]) by ****************** (8.13.4/***/8.13.4) with ESMTP id j5FJNod4006646; Wed, 15 Jun 2005 20:24:07 +0100 Received: from adecco.com by .adecco.com (Postfix) with SMTP id F Message-ID: <01c401c57209$b50bd1d0$redacted@ATNLD> From: "melodie sunyich" <redacted@adecco.com> To: <age@*******************>, <**************************>, <tj@*******************>, <msbaine@*******************>, <dcrowther@*******************>, <it@*******************>, <tbaker@*******************>, <davidbooth@*******************>, <mhillary@*******************>, <petec@*******************>, <rmckay@*******************>, <pgarcia@*******************>, <pboakes@*******************>, <dix@*******************>, <shaw@*******************> Subject: Start y0ur trading day with a bang Date: Wed, 15 Jun 2005 19:24:06 -0600 MIME-Version: 1.0 Content-Type: multipart/alternative; boundary="----=_NextPart_000_01C1_01C571DF.CC35C9D0" X-Priority: 3 X-MSMail-Priority: Normal X-Mailer: Microsoft Outlook Express 6.00.2800.1158 X-MimeOLE: Produced By Microsoft MimeOLE V6.00.2800.1165 Apparently-To: ************************** This is a multi-part message in MIME format. ------=_NextPart_000_01C1_01C571DF.CC35C9D0 Content-Type: text/plain; charset="iso-8859-1" Content-Transfer-Encoding: 7Bit Big news expected This should invoke large gains PGCN has gained over $1.00 since Monday the 13th. This stock will explode the end of this week. Do not wait until it is too late. New news expected this week. Expected 7 day price $9.00 (SYMBOL: PGCN) Price: $1.88 (up from $.50 Last 4 days of trading) Short Term Target: $27-$35 12month Target: $50.00 ************************************************ Tuesday June 14, 10:00 am ET BIG NEWS TODAY HARBIN, China, June 14 Xinhua PRNewswire FirstCall Pingchuan Pharmaceutical Inc. (OTC Bulletin Board: PGCN - News; ''PGCN'') announced today that PGCN signed a Regional Distribution Contract with Beijing Pingchuan Tianzhi Medical Technology Development Center (''TIANZHI''), a subsidiary wholly invested by Pingchuan Pharmaceutical Inc ************************************************* Pingchuan Summary: Harbin Pingchuan Pharmaceutical Holding Co., Ltd. ("PINGCHUAN") (PGCN) was established in March 2001 in Harbin city, P.R.China. It is a modernized pharmaceutical manufacturer with first-class medical R&D ability, pioneered medicine products, and well-established marketing network. Harbin Pingchuan Traditional Chinese Medicine Research Institute was established in June 1998, with a registered capital of US $120,000. Currently it has 60 employees, 20 of them are professionals and experts on diabetes. Functioning as the R&D base of PINGCHUAN, the institute focuses on R & D of new medicines, particularly those on diabetes. Since the establishment of 2001, PINGCHUAN has developed a series of diabetes medicine, including antibiotics, chemical medical capsules and traditional Chinese medicine. Kang Da Glycosuria Capsule is one of the successful products of PINGCHUAN for treating diabetes. It was first developed in 1998 and introduced to the market in 2001. PINGCHUAN also produces medical intermediates and pharmaceutical preparations, medical instruments, health care food and other related products. PINGCHUAN has well-established marketing network and sale branches, including about 180,000 retail pharmacies/drugstores across China, agency network in major cities like Beijing, Shanghai, Guangzhou, and Xi'an, special sales counter at drug chain stores in key regions, residence community clinic sale and promotion, as well as internet marketing through the company's website. The marketing network of PINGCHUAN covers more than 50% districts of China and exports to US, Japan, Russia, and south-eastern Asia. Example: CWTD in February 2004 at 90 cents before it went to $8.50, an increase of 800 PERCENT !! In March MAMA at 3.95 shortly before hitting a high of $13.30 over 400 PERCENT !!! But We expect much more from PGCN, Sit back and watch. embargoTheAfrican Union has also condemnedMrGnassingbe's refusal to leave wasspeakingafter meeting a highlevel Togolesedelegationin Nigeria Rival rallies Undertheoriginal constitution which was ------=_NextPart_000_01C1_01C571DF.CC35C9D0-- -- All postings to news.admin.net-abuse.sightings are unconfirmed and unverified unless stated otherwise by the moderators. All opinions expressed above are considered the opinions of the original poster, not the moderators or their respective employers. For a copy of the guidelines to this group, see: http://www.killfile.org/~tskirvin/nana/ -+-+-+- NEXT SEGMENT -+-+-+- Segment of length 6011 From redacted@cybernothing.org Thu Jun 16 13:00:36 2005 Message-ID: <redacted@localhost.localdomain> From: redacted@no.thanks Subject: [email] Start y0ur trading day with a bang Approved: redacted@cybernothing.org Followup-To: news.admin.net-abuse.email Newsgroups: news.admin.net-abuse.sightings Organization: VeriMod (<URL:http://www.killfile.org/~tskirvin/verimod/>) Processed-By: Bob the NANAS ModBot <redacted@cybernothing.org> Verimod-Status: Thu Jun 16 13:00:36 2005 - posted X-Auth: PGPMoose V1.1 PGP news.admin.net-abuse.sightings iD8DBQFCsb5Ev1i8LqUfqQURAgzyAJwKLPGOsxSxL9M36lbTrfyHJO0+zACfVaui pzDrSrV8Aa8U+3IThCipkXk=109e X-Group-Homepage: http://www.killfile.org/~tskirvin/nana/ X-Mail-Path: localhost.localdomain [UNTRUSTED]!redacted@localhost.localdomain X-Modbot: Bob the NANAS ModBot <redacted@cybernothing.org> X-Original-Date: Thu, 16 Jun 2005 18:37:56 GMT X-Original-To: redacted@killfile.org X-Submissions-To: redacted@cybernothing.org Spam. Unsolicited e-mail report follows: Memo #249007 (4624) From redacted@adecco.com Wed Jun 15 20:24:09 2005 Received: from ****************** (****************** [***************]) by **********.********* (8.11.3/***/8.11.2) with ESMTP id j5FJO9f22435; Wed, 15 Jun 2005 20:24:09 +0100 (BST) X-Envelope-From: redacted@adecco.com Received: from charter.com (18.98.205.68.cfl.res.rr.com [68.205.98.18]) by ****************** (8.13.4/***/8.13.4) with ESMTP id j5FJNod4006646; Wed, 15 Jun 2005 20:24:07 +0100 Received: from adecco.com by .adecco.com (Postfix) with SMTP id F Message-ID: <01c401c57209$b50bd1d0$redacted@ATNLD> From: "melodie sunyich" <redacted@adecco.com> To: <age@*******************>, <**************************>, <tj@*******************>, <msbaine@*******************>, <dcrowther@*******************>, <it@*******************>, <tbaker@*******************>, <davidbooth@*******************>, <mhillary@*******************>, <petec@*******************>, <rmckay@*******************>, <pgarcia@*******************>, <pboakes@*******************>, <dix@*******************>, <shaw@*******************> Subject: Start y0ur trading day with a bang Date: Wed, 15 Jun 2005 19:24:06 -0600 MIME-Version: 1.0 Content-Type: multipart/alternative; boundary="----=_NextPart_000_01C1_01C571DF.CC35C9D0" X-Priority: 3 X-MSMail-Priority: Normal X-Mailer: Microsoft Outlook Express 6.00.2800.1158 X-MimeOLE: Produced By Microsoft MimeOLE V6.00.2800.1165 Apparently-To: ************************** This is a multi-part message in MIME format. ------=_NextPart_000_01C1_01C571DF.CC35C9D0 Content-Type: text/plain; charset="iso-8859-1" Content-Transfer-Encoding: 7Bit Big news expected This should invoke large gains PGCN has gained over $1.00 since Monday the 13th. This stock will explode the end of this week. Do not wait until it is too late. New news expected this week. Expected 7 day price $9.00 (SYMBOL: PGCN) Price: $1.88 (up from $.50 Last 4 days of trading) Short Term Target: $27-$35 12month Target: $50.00 ************************************************ Tuesday June 14, 10:00 am ET BIG NEWS TODAY HARBIN, China, June 14 Xinhua PRNewswire FirstCall Pingchuan Pharmaceutical Inc. (OTC Bulletin Board: PGCN - News; ''PGCN'') announced today that PGCN signed a Regional Distribution Contract with Beijing Pingchuan Tianzhi Medical Technology Development Center (''TIANZHI''), a subsidiary wholly invested by Pingchuan Pharmaceutical Inc ************************************************* Pingchuan Summary: Harbin Pingchuan Pharmaceutical Holding Co., Ltd. ("PINGCHUAN") (PGCN) was established in March 2001 in Harbin city, P.R.China. It is a modernized pharmaceutical manufacturer with first-class medical R&D ability, pioneered medicine products, and well-established marketing network. Harbin Pingchuan Traditional Chinese Medicine Research Institute was established in June 1998, with a registered capital of US $120,000. Currently it has 60 employees, 20 of them are professionals and experts on diabetes. Functioning as the R&D base of PINGCHUAN, the institute focuses on R & D of new medicines, particularly those on diabetes. Since the establishment of 2001, PINGCHUAN has developed a series of diabetes medicine, including antibiotics, chemical medical capsules and traditional Chinese medicine. Kang Da Glycosuria Capsule is one of the successful products of PINGCHUAN for treating diabetes. It was first developed in 1998 and introduced to the market in 2001. PINGCHUAN also produces medical intermediates and pharmaceutical preparations, medical instruments, health care food and other related products. PINGCHUAN has well-established marketing network and sale branches, including about 180,000 retail pharmacies/drugstores across China, agency network in major cities like Beijing, Shanghai, Guangzhou, and Xi'an, special sales counter at drug chain stores in key regions, residence community clinic sale and promotion, as well as internet marketing through the company's website. The marketing network of PINGCHUAN covers more than 50% districts of China and exports to US, Japan, Russia, and south-eastern Asia. Example: CWTD in February 2004 at 90 cents before it went to $8.50, an increase of 800 PERCENT !! In March MAMA at 3.95 shortly before hitting a high of $13.30 over 400 PERCENT !!! But We expect much more from PGCN, Sit back and watch. embargoTheAfrican Union has also condemnedMrGnassingbe's refusal to leave wasspeakingafter meeting a highlevel Togolesedelegationin Nigeria Rival rallies Undertheoriginal constitution which was ------=_NextPart_000_01C1_01C571DF.CC35C9D0-- -- All postings to news.admin.net-abuse.sightings are unconfirmed and unverified unless stated otherwise by the moderators. All opinions expressed above are considered the opinions of the original poster, not the moderators or their respective employers. For a copy of the guidelines to this group, see: http://www.killfile.org/~tskirvin/nana/